
Sign up to save your podcasts
Or


Will new clinical trials for Covid-19 give remdesivir a second chance?Ben Valsler introduces the broad-spectrum antiviral that didn't quite make it as the Ebola drug it was originally planned to be.
By Chemistry World4.7
182182 ratings
Will new clinical trials for Covid-19 give remdesivir a second chance?Ben Valsler introduces the broad-spectrum antiviral that didn't quite make it as the Ebola drug it was originally planned to be.

537 Listeners

1,723 Listeners

523 Listeners

296 Listeners

390 Listeners

43 Listeners

983 Listeners

15 Listeners